Tagged with

The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed in size by Thailand, a country with one quarter the population of Indonesia’s vast archipelago. Some pundits see the country…

Korea   Already an economic powerhouse thriving on export-driven industries such as electronics, automotive and ship-building, South Korea is now looking to boost its potential in the life sciences and to move towards an innovation-based economy. Though it may traditionally be known in the West as ‘The Land of the Morning…

Over the last several years we have seen a shift in clinical research from traditional healthcare markets to Asia.  How do you see this trend evolving in the coming years? Right now Asia provides an excellent clinical research environment compared to ten years ago.  I see Asian clinical trial activity…

Petrone group was created in 1965, based on your parents’ Carmine and Fernanda’s entrepreneurial spirit. They survived through times of challenges for Italian groups and maintained their independence. In your opinion, which main milestones of the group’s history were keys to its success, enabled the company not to fail and…

Scharper’s history in the Italian market begins in 1958, but the company as we see it today was really created in the mid nineties, when you founded La Farmochimica Italiana (LFI) with your father Dr Lino Cartolari and later acquired Scharper Spa from HMR. What was the rationale behind buying…

Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion in sales in 2007 ( +38% vs 2006), doubling the operational income and for the first time in the last…

  Australia, the “land down under” to many Westerners, is sometimes left at just that — out of sight, and out of mind. But investors who ignore Australia do so at their own peril. Because of its distance from the rest of the West, the country is often overlooked for…

Mexico, which has over a hundred million inhabitants, has become the world’s ninth biggest pharmaceutical market and the largest in Latin America, surpassing Brazil for the first time in its history. The sector already represents 1.18% of the national GDP, generating US$9,244 million (source Canifarma). The private sector market is…

Greece Greece’s contributions to health are world-renowned, whether physical through its Mediterranean diet and climate, or mental as the genesis of western philosophy and mathematics. Less well-known, however, are its modern-day activities in the pharmaceutical industry, where the blossoming market is distinctive for its diversity despite a small size of 11…

When Singapore became independent in 1965, the smart money was not on this small South East Asian island with limited natural resources having a prosperous future. However, thanks mainly to appropriate policy making, Singapore went on during the rest of the 20th century to become one of the wealthiest nations…

Brazil   With its huge market of 186 million people; its current position as the largest pharma market in Latin America, with strong growth projected; the influx of foreign and local investment into its pharma market; its reputation for conducting high-quality clinical research; and its incredible biological diversity, Brazil seems poised…

“India, as a manufacturing hub, offers safe, effective, quality medicines, at the very best prices. Now, we are on our way to become a R&D hub.” For Dilip Shah, General Secretary of the Indian Pharmaceutical Alliance (IPA), India is currently on its way to undertake one of the greatest transformations…